Randomized Phase II Trial Evaluating Two Sequential Treatments in First Line of Metastatic Pancreatic Cancer: Results of the PANOPTIMOX-PRODIGE 35 Trial Newly diagnosed patients enrolled on the COG ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback